A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

NCT06277934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: RGT001-075
DRUG: Placebo

Sponsor

Regor Pharmaceuticals Inc.